Expert Opinion on Biological Therapy

Papers
(The H4-Index of Expert Opinion on Biological Therapy is 27. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-04-01 to 2024-04-01.)
ArticleCitations
Platelet-rich plasma for the treatment of knee osteoarthritis: an expert opinion and proposal for a novel classification and coding system119
Adipose-derived stromal stem cells (ASCs) as a new regenerative immediate therapy combating coronavirus (COVID-19)-induced pneumonia65
Addressing high dose AAV toxicity – ‘one and done’ or ‘slower and lower’?61
Antibody-based immunotherapeutics and use of convalescent plasma to counter COVID-19: advances and prospects61
Mesothelin-targeted CAR-T cell therapy for solid tumors58
Development of SARS-CoV-2 vaccines: should we focus on mucosal immunity?57
Recent developments of RNA-based vaccines in cancer immunotherapy56
Status update in the use of cell-penetrating peptides for the delivery of macromolecular therapeutics55
Sacituzumab govitecan, a novel, third-generation, antibody-drug conjugate (ADC) for cancer therapy54
Antibody-drug conjugates (ADCs) delivering pyrrolobenzodiazepine (PBD) dimers for cancer therapy50
Core decompression isolated or combined with bone marrow-derived cell therapies for femoral head osteonecrosis46
Will plant-made biopharmaceuticals play a role in the fight against COVID-19?43
Brexucabtagene autoleucel for the treatment of relapsed/refractory mantle cell lymphoma41
An overview of process development for antibody-drug conjugates produced by chemical conjugation technology40
One-year effectiveness, retention rate, and safety of secukinumab in ankylosing spondylitis and psoriatic arthritis: a real-life multicenter study40
Therapeutic monoclonal antibodies for COVID-19 management: an update39
New frontiers in personalized medicine in psoriasis37
Characteristic of chronic plaque psoriasis patients treated with biologics in Italy during the COVID-19 Pandemic: Risk analysis from the PSO-BIO-COVID observational study36
A review of antibody-based therapeutics targeting G protein-coupled receptors: an update34
A tool with many applications: vesicular stomatitis virus in research and medicine34
Targeting the complement system in neuromyelitis optica spectrum disorder33
Immunotherapy for SARS-CoV-2: potential opportunities31
Nivolumab for the treatment of hepatocellular carcinoma30
Treating psoriasis in the elderly: biologics and small molecules30
Progress with stem cell therapies for tendon tissue regeneration30
A comprehensive review on sarilumab in COVID-1930
A randomized blinded retrospective study: the combined use of micro-needling technique, low-level laser therapy and autologous non-activated platelet-rich plasma improves hair re-growth in patients wi29
Antibody-drug conjugates in metastatic triple negative breast cancer: a spotlight on sacituzumab govitecan, ladiratuzumab vedotin, and trastuzumab deruxtecan27
The potential role of tumor-derived exosomes in diagnosis, prognosis, and response to therapy in cancer27
0.076550006866455